Detalhe da pesquisa
1.
Impact of acetaminophen on the efficacy of immunotherapy in cancer patients.
Ann Oncol
; 33(9): 909-915, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35654248
2.
Circulating L-arginine predicts the survival of cancer patients treated with immune checkpoint inhibitors.
Ann Oncol
; 33(10): 1041-1051, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35850444
3.
Plasma proteomics identifies leukemia inhibitory factor (LIF) as a novel predictive biomarker of immune-checkpoint blockade resistance.
Ann Oncol
; 32(11): 1381-1390, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34416362
4.
Mature tertiary lymphoid structure is a specific biomarker of cancer immunotherapy and does not predict outcome to chemotherapy in non-small-cell lung cancer.
Ann Oncol
; 33(10): 1084-1085, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35764273
5.
Pembrolizumab in soft-tissue sarcomas with tertiary lymphoid structures: a phase 2 PEMBROSARC trial cohort.
Nat Med
; 28(6): 1199-1206, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35618839
6.
Programmed cell death 1 (PD-1) targeting in patients with advanced osteosarcomas: results from the PEMBROSARC study.
Eur J Cancer
; 119: 151-157, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31442817
7.
Circulating Antibodies to IDO/THO Pathway Metabolites in Alzheimer's Disease.
Int J Alzheimers Dis
; 20102010 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-20721333